Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: Study design and recruitment

BMC Family Practice

Volumn 9, Issue , 2008, Pages

  De Bot, Cindy M A ^a   Moed, Heleen ^a   Berger, Marjolein Y ^a   Röder, Esther ^a   De Groot, Hans ^a   De Jongste, Johan C ^b   Van Wijk, Roy Gerth ^a   Wouden, Johannes C Van Der ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; HOUSE DUST ALLERGEN; PLACEBO; PREDNISOLONE; PREDNISONE;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; GRASS POLLEN; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NASAL SYMPTOM SCORE; NETHERLANDS; POLLEN; POSTAL MAIL; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RAST TEST; SAMPLE SIZE; SCORING SYSTEM; SCREENING TEST; SYMPTOM; TELECONSULTATION; TREE POLLEN; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ANIMAL; DERMATOPHAGOIDES PTERONYSSINUS; IMMUNOLOGY; METHODOLOGY; MULTICENTER STUDY; PERENNIAL RHINITIS; PRIMARY HEALTH CARE; QUALITY OF LIFE; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHILD; DERMATOPHAGOIDES PTERONYSSINUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; NETHERLANDS; PRIMARY HEALTH CARE; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 55849112659     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-9-59     Document Type: Article

References (26)

1. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. A Des Roches L Paradis JL Menardo S Bouges JP Daures J Bousquet, J Allergy Clin Immunol 1997 99 450 3 10.1016/S0091-6749(97)70069-1 9111487
2. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. GB Pajno G Barberio F De Luca L Morabito S Parmiani, Clin Exp Allergy 2001 31 1392 7 10.1046/j.1365-2222.2001.01161.x 11591189
3. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. F Purello-D'Ambrosio S Gangemi RA Merendino S Isle P Puccinelli S Parmiani L Ricciardi, Clin Exp Allergy 2001 31 1295 302 10.1046/j.1365-2222.2001.01027.x 11529901
4. Allergen injection immunotherapy for seasonal allergic rhinitis. MA Calderon B Alves M Jacobson B Hurwitz A Sheikh S Durham, Cochrane Database Syst Rev 2007 1 CD001936 17253469
5. Incorrect allergy injections: allergists' experiences and recommendations for prevention. DW Aaronson TK Gandhi, J Allergy Clin Immunol 2004 113 1117 21 10.1016/j.jaci.2004.01.756 15208593
6. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. DI Bernstein M Wanner L Borish GM Liss, J Allergy Clin Immunol 2004 113 1129 36 10.1016/j.jaci.2004.02.006 15208595
7. Safety of sublingual-swallow immunotherapy in children and adults. C Andre C Vatrinet S Galvain F Carat H Sicard, Int Arch Allergy Immunol 2000 121 229 34 10.1159/000024322 10729782
8. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. VD Rienzo M Minelli A Musarra R Sambugaro S Pecora WG Canonica G Passalacqua, Clin Exp Allergy 2005 35 560 4 10.1111/j.1365-2222.2005.02219.x 15898975
9. Is sublingual immunotherapy clinically effective? HJ Malling, Curr Opin Allergy Clin Immunol 2002 2 523 31 10.1097/00130832-200212000-00008 14752336
10. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. M Penagos E Compalati F Tarantini R Baena-Cagnani J Huerta G Passalacqua GW Canonica, Ann Allergy Asthma Immunol 2006 97 141 8 16937742
11. Immunotherapy in children and adolescents with allergic rhinoconjuctivitis: a systematic review. E Röder MY Berger H De Groot R van Wijk Gerth, Pediatr Allergy Immunol 2008 19 3 197 207 10.1111/j.1399-3038.2007. 00648.x 18221463
12. Sublingual immunotherapy for allergic rhinitis. DR Wilson LI Torres SR Durham, Cochrane Database Syst Rev 2003 CD002893 12804442
13. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland. C Bachert P van Cauwenberge N Khaltaev, Allergy 2002 57 841 55 10.1034/j.1398-9995.2002.23625.x 12169183
14. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Bousquet R Lockey HJ Malling, Allergy 1998 53 1 42 10.1111/j.1398-9995.1998.tb04081.x
15. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. MI Asher U Keil HR Anderson, Eur Respir J 1995 8 483 91 10.1183/09031936.95.08030483 7789502
16. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. EF Juniper GH Guyatt J Dolovich, J Allergy Clin Immunol 1994 93 413 23 10.1016/0091-6749(94)90349-2 8120268
17. Measuring quality of life in children with rhinoconjunctivitis. EF Juniper WC Howland NB Roberts AK Thompson DR King, J Allergy Clin Immunol 1998 101 163 70 10.1016/S0091-6749(98)70380-X 9500748
18. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. I Terreehorst E Hak AJ Oosting Z Tempels-Pavlica JG de Monchy CA Bruijnzeel-Koomen RC Aalberse R van Wijk Gerth, N Engl J Med 2003 349 237 46 10.1056/NEJMoa023171 12867607
19. Methodology and quality of immunotherapy trials. HJ Malling, Allergy 2004 59 482 4 10.1111/j.1398-9995.2004.00501.x 15080827
20. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. CK Niu WY Chen JL Huang KH Lue JY Wang, Respir Med 2006 100 1374 83 10.1016/j.rmed.2005.11.016 16403616
21. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. N Pham-Thi P Scheinmann R Fadel A Combebias C Andre, Pediatr Allergy Immunol 2007 18 47 57 10.1111/j.1399-3038. 2006.00475.x 17295799
22. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. GW Canonica CE Baena-Cagnani J Bousquet PJ Bousquet RF Lockey HJ Malling G Passalacqua P Potter E Valovirta, Allergy 2007 62 317 24 10.1111/j.1398-9995.2006.01312.x 17298350
23. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. GB Pajno L Morabito G Barberio S Parmiani, Allergy 2000 55 842 9 10.1034/j.1398-9995.2000.00495.x 11003448
24. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. HJ Bueving RM Bernsen JC de Jongste LW van Suijlekom-Smit GF Rimmelzwaan AD Osterhaus MP Rutten-van Mölken S Thomas JC van der Wouden, Am J Respir Crit Care Med 2004 169 488 93 10.1164/rccm.200309- 1251OC 14656755
25. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. MJ Tasche JC van der Wouden JH Uijen BP Ponsioen RM Bernsen LW van Suijlekom-Smit JC de Jongste, Lancet 1997 350 1060 4 10.1016/S0140-6736(97)05333-6 10213547
26. Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. JC van der Wouden AH Blankenstein MJ Huibers DA van der Windt WA Stalman AP Verhagen, J Clin Epidemiol 2007 60 819 24 10.1016/j.jclinepi.2006.11. 010 17606178